ES2155518T3 - Compuestos antimicrobianos de amplio espectro y metodo de uso. - Google Patents

Compuestos antimicrobianos de amplio espectro y metodo de uso.

Info

Publication number
ES2155518T3
ES2155518T3 ES95909556T ES95909556T ES2155518T3 ES 2155518 T3 ES2155518 T3 ES 2155518T3 ES 95909556 T ES95909556 T ES 95909556T ES 95909556 T ES95909556 T ES 95909556T ES 2155518 T3 ES2155518 T3 ES 2155518T3
Authority
ES
Spain
Prior art keywords
indolicidin
survival
growth
provides
spectro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909556T
Other languages
English (en)
Inventor
Michael E Selsted
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of ES2155518T3 publication Critical patent/ES2155518T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION INCLUYE ANALOGOS DE INDOLICIDINA, QUE SON PEPTIDOS RICOS EN TRIPTOFANO QUE TIENEN BASICAMENTE LA MISMA SECUENCIA DE AMINOACIDOS QUE LA INDOLICIDINA NATURAL Y QUE MUESTRAN UNA ACTIVIDAD ANTIMICROBIANA CON UN AMPLIO ESPECTRO Y UNA SELECTIVIDAD ANTIMICROBIANA, EN COMPARACION CON LA INDOLICIDINA NATURAL. LA INVENCION TAMBIEN INCLUYE METODOS PARA UTILIZAR UN ANALOGO DE INDOLICIDINA PARA INHIBIR O PREVENIR LA SUPERVIVENCIA O EL CRECIMIENTO DE UN MICROORGANISMO EN UN ENTORNO CAPAZ DE MANTENER DICHA SUPERVIVENCIA O CRECIMIENTO. LA INVENCION INCLUYE, POR EJEMPLO, METODOS DE ADMINISTRACION DE UNA CANTIDAD EFICAZ DE UN ANALOGO DE INDOLICIDINA EN UN ENTORNO CAPAZ DE MANTENER LA SUPERVIVENCIA O EL CRECIMIENTO DE UN MICROORGANISMO.
ES95909556T 1994-02-16 1995-02-10 Compuestos antimicrobianos de amplio espectro y metodo de uso. Expired - Lifetime ES2155518T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/197,205 US5547939A (en) 1991-06-14 1994-02-16 Broad spectrum antimicrobial compounds and methods of use

Publications (1)

Publication Number Publication Date
ES2155518T3 true ES2155518T3 (es) 2001-05-16

Family

ID=22728460

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909556T Expired - Lifetime ES2155518T3 (es) 1994-02-16 1995-02-10 Compuestos antimicrobianos de amplio espectro y metodo de uso.

Country Status (14)

Country Link
US (1) US5547939A (es)
EP (1) EP0750506B1 (es)
JP (2) JP3147904B2 (es)
AT (1) ATE200426T1 (es)
AU (1) AU683725B2 (es)
CA (1) CA2179286C (es)
DE (1) DE69520668T2 (es)
DK (1) DK0750506T3 (es)
ES (1) ES2155518T3 (es)
GR (1) GR3036092T3 (es)
IL (1) IL112641A (es)
PT (1) PT750506E (es)
WO (1) WO1995022338A1 (es)
ZA (1) ZA951276B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
WO1997008199A2 (en) * 1995-08-23 1997-03-06 University Of British Columbia Antimicrobial cationic peptides and methods of screening for the same
CA2263164A1 (en) * 1996-08-15 1998-02-19 Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
EP1174439B1 (en) * 1996-08-21 2008-10-08 Migenix Inc. Compositions and methods for treating infections using analogues of indolicidin
AU2605099A (en) * 1998-02-25 1999-09-15 Micrologix Biotech, Inc. Indolicidin and cationic peptides conjugated with polymers
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US6303575B1 (en) 1998-05-12 2001-10-16 The Regents Of The University Of California Indolicidin analogs and methods of using same
WO1999065506A2 (en) * 1998-06-12 1999-12-23 Micrologix Biotech Inc. Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
US6444645B1 (en) * 1998-06-18 2002-09-03 The Regents Of The University Of California Crosslink-stabilized indolicidin analogs
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6096225A (en) * 1998-09-11 2000-08-01 Nalco Chemical Company Method of controlling biofouling in aqueous media using antimicrobial emulsions
WO2000026344A1 (en) * 1998-10-30 2000-05-11 Interlink Biotechnologies Llc Peptides with enhanced stability to protease degradation
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
GB0005702D0 (en) * 2000-03-09 2000-05-03 Alpharma As Method
AU2001243247A1 (en) * 2000-02-25 2001-09-03 Smith Kline Beecham Corporation Methods of screening for antimicrobial compounds
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
AU2001255666A1 (en) * 2000-04-26 2001-11-07 Wisconsin Alumni Research Foundation Triaryl cation antibiotics from environmental dna
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
CA2457885A1 (en) * 2001-08-24 2003-03-06 Micrologix Biotech Inc. Antimicrobial and anti-inflammatory peptides
WO2003091429A1 (fr) * 2002-04-25 2003-11-06 Toagosei Co.,Ltd. Polypeptide microbicide et ses utilisations
US7119070B2 (en) * 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
US20030040032A1 (en) * 2002-08-23 2003-02-27 Demarsh Peter L. Methods of screening for antimicrobial compounds
US7674771B2 (en) * 2003-10-29 2010-03-09 Toagosei Co., Ltd Antimicrobial peptides and utilization of the same
JP4507080B2 (ja) * 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
JP4730584B2 (ja) 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
US20080255052A1 (en) * 2004-12-23 2008-10-16 The Regents Of The University Of California Immunologic regulation by theta defensins
US20090030179A1 (en) * 2005-02-15 2009-01-29 Toagosei Co., Ltd Antimicrobial peptide and use thereof
AU2007288080B2 (en) * 2006-08-21 2013-07-04 The University Of British Columbia Small cationic antimicrobial peptides
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
US7824557B2 (en) * 2007-08-08 2010-11-02 General Electric Company Method for controlling microbial biofilm in aqueous systems
US20110052655A1 (en) * 2007-08-08 2011-03-03 Wilson Kurt Whitekettle Methods and vesicles for controlling protozoa
US7785478B2 (en) * 2007-08-08 2010-08-31 General Electric Company Method for controlling protozoa that harbor bacteria
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5324716A (en) * 1991-06-14 1994-06-28 Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use

Also Published As

Publication number Publication date
AU1747895A (en) 1995-09-04
WO1995022338A1 (en) 1995-08-24
AU683725B2 (en) 1997-11-20
ATE200426T1 (de) 2001-04-15
EP0750506B1 (en) 2001-04-11
GR3036092T3 (en) 2001-09-28
US5547939A (en) 1996-08-20
JP2001172297A (ja) 2001-06-26
DE69520668T2 (de) 2001-09-06
DE69520668D1 (de) 2001-05-17
EP0750506A1 (en) 1997-01-02
CA2179286C (en) 1999-09-21
CA2179286A1 (en) 1995-08-24
PT750506E (pt) 2001-09-28
IL112641A (en) 2000-07-26
ZA951276B (en) 1995-10-23
IL112641A0 (en) 1995-05-26
DK0750506T3 (da) 2001-05-07
JP3147904B2 (ja) 2001-03-19
EP0750506A4 (en) 1998-10-14
JPH09509175A (ja) 1997-09-16

Similar Documents

Publication Publication Date Title
ES2155518T3 (es) Compuestos antimicrobianos de amplio espectro y metodo de uso.
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
CA2318398A1 (en) Novel peptides having biological activity
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
EP0956029A4 (en) CYCLIC PEPTIDES WITH EXTENDED ANTIMICROBIAL ACTIVITY
ES2172506T3 (es) Peptidos sinteticos para la detoxificacion de endotoxinas bacterianas y para el tratamiento de choques septicos.
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
KR0180256B1 (en) Bpc peptides, their preparation and use
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
AU4916597A (en) Semi-synthetic studies toward didemnin analogues
ZA93129B (en) Hemoregulatory peptides
WO2001012668A9 (en) Cathelicidin-derived peptides with broad spectrum antimicrobial activity
AU2001278884A1 (en) Anti-hiv and anti-tumor peptides and fragments of lysozyme
GB2283974A (en) Allatostatins and their use
WO2000020441A3 (en) Cyclic peptides as antifungal agents
ES2127516T3 (es) Peptidos para inhibir la liberacion de pepsina.
YU8104A (sh) Oligopeptidi osteogenog rasta kao stimulatori hematopoeze

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 750506

Country of ref document: ES